"BOSTON, MA â€” In a large study, middle-aged Americans who drank up to seven alcoholic drinks a week were less likely to develop heart failure during a 24-year follow-up than their peers who abstained, drank more, or were former drinkers. These fin"...
DOSAGE AND ADMINISTRATION
The recommended dosage of MULTAQ is 400 mg twice daily in adults. MULTAQ should be taken as one tablet with the morning meal and one tablet with the evening meal.
Treatment with Class I or III antiarrhythmics (e.g., amiodarone, flecainide, propafenone, quinidine, disopyramide, dofetilide, sotalol) or drugs that are strong inhibitors of CYP3A (e.g., ketoconazole) must be stopped before starting MULTAQ [see CONTRAINDICATIONS].
Dosage Forms And Strengths
MULTAQ 400 mg tablets are provided as white film-coated tablets for oral administration, oblong-shaped, engraved with a double wave marking on one side and “4142” code on the other side.
Storage And Handling
MULTAQ 400-mg tablets are provided as white film-coated tablets for oral administration, oblong-shaped, engraved with a double wave marking on one side and “4142” code on the other side in:
Bottles of 60 tablets, NDC 0024-4142-60
Bottles of 180 tablets, NDC 0024-4142-18
Bottles of 500 tablets NDC 0024-4142-50
Box of 10 blisters (10 tablets per blister) NDC 0024-4142-10
Store at 25°C (77°F): excursions permitted to 15-30°C (59-86°F), [see WARNINGS AND PRECAUTIONS].
Manufactured by Sanofi Winthrop Industrie 1, rue de la Vierge 33440 Ambares, France. sanofi-aventis U.S. LLC Bridgewater, NJ 08807 A Sanofi Company. Revised: Jan 2014.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 2/10/2014
Additional Multaq Information
Multaq - User Reviews
Multaq User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.